- Miklowitz, David J;
- Addington, Jean M;
- O'Brien, Mary P;
- Denenny, Danielle M;
- Weintraub, Marc J;
- Zinberg, Jamie L;
- Mathalon, Daniel H;
- Cornblatt, Barbara A;
- Friedman-Yakoobian, Michelle S;
- Stone, William S;
- Cadenhead, Kristin S;
- Woods, Scott W;
- Sugar, Catherine A;
- Cannon, Tyrone D;
- Bearden, Carrie E
Aims
Young people with attenuated psychotic symptoms (APS), brief intermittent psychosis, and/or genetic risk and functional deterioration are at high risk for developing psychotic disorders. In a prior trial, family-focused therapy for clinical high risk youth (FFT-CHR) was more effective than brief psychoeducation in reducing APS severity over 6 months. This 7-site trial will compare the efficacy of FFT-CHR to a psychoeducational and supportive intervention (enhanced care) on APS and social functioning in CHR individuals over 18 months.Methods
Participants (N = 220, ages 13-25 years) with a CHR syndrome will be randomly assigned to FFT-CHR (18 1-h sessions of family psychoeducation and communication/problem-solving skills training) or enhanced care (3 1-h family psychoeducational sessions followed by 5 individual support sessions), both given over 6 months. Participants will rate their weekly progress during treatment using a mobile-enhanced online platform. Family communication will be assessed in a laboratory interactional task at baseline and post-treatment. Independent evaluators will assess APS (primary outcome) and psychosocial functioning (secondary outcome) every 6 months over 18 months.Results
We hypothesize that, compared to enhanced care, FFT-CHR will be associated with greater improvements in APS and psychosocial functioning over 18 months. Secondarily, improvements in family communication over 6 months will mediate the relationship between treatment condition and primary and secondary outcomes over 18 months. The effects of FFT-CHR are predicted to be greater in individuals with higher baseline risk for psychosis conversion.Conclusions
Results of the trial will inform treatment guidelines for individuals at high risk for psychosis.